TherapeuticsMD
TXMD
TXMD
146 hedge funds and large institutions have $931M invested in TherapeuticsMD in 2019 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 1.57% → 1.59% (+0.02%)
8% less call options, than puts
Call options by funds: $2.55M | Put options by funds: $2.77M
Holders
146
Holding in Top 10
2
Calls
$2.55M
Puts
$2.77M
Top Buyers
| 1 | +$21.2M | |
| 2 | +$15.3M | |
| 3 | +$4.61M | |
| 4 |
DCM
Daruma Capital Management
New York
|
+$3.65M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.92M |
Top Sellers
| 1 | -$30.9M | |
| 2 | -$6.2M | |
| 3 | -$5.71M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$2.66M |
| 5 |
First Eagle Investment Management
New York
|
-$2.09M |